AKR1B10 and Familial prostate cancer: Previous studies have established high expression of AKR1B10 in several cancers, including cholangiocarcinoma, hepatocellular carcinoma, lung adenocarcinoma, lung squamous cell carcinoma, prostate cancer, and uterine endometrial cancer, compared to adjacent normal tissues.